Dysphagia after sequential chemoradiation therapy for advanced head and neck cancer.

Department of Surgery/Division of Otolaryngology, at the Brigham and Women's Hospital and the Dana Farber Cancer Institute, Boston, MA 02115, USA.
Otolaryngology Head and Neck Surgery (Impact Factor: 1.73). 07/2006; 134(6):916-22. DOI: 10.1016/j.otohns.2006.02.001
Source: PubMed

ABSTRACT Assess impact of sequential chemoradiation therapy (SCRT) for advanced head and neck cancer (HNCA) on swallowing, nutrition, and quality of life.
Prospective cohort study of 59 patients undergoing SCRT for advanced head and neck cancer. Follow-up median was 47.5 months.
Regional Cancer Center.
Median time to gastrostomy tube removal was 21 weeks. Eighteen of 23 patients who underwent modified barium swallow demonstrated aspiration; none developed pneumonia. Six of 7 with pharyngoesophageal stricture underwent successful dilatation. Functional Assessment of Cancer Therapy-Head and Neck Scale questionnaires at median 6 months after treatment revealed "somewhat" satisfaction with swallowing. At the time of analysis, 97% have the gastronomy tube removed and take soft/regular diet.
Early after treatment dysphagia adversely affected weight, modified barium swallow results, and quality of life. Diligent swallow therapy, and dilation as needed, allowed nearly all patients to have their gastronomy tubes removed and return to a soft/regular diet.
Dysphagia is significant after SCRT but generally slowly recovers 6 to 12 months after SCRT.

1 Bookmark
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background and purpose To evaluate the course of health-related quality of life (HRQOL) from diagnosis to 2 years follow-up in patients with head and neck cancer (HNSCC) treated with chemoradiation (CRT). Materials and methods 164 patients completed the EORTC QLQ-C30 and QLQ-H&N35 questionnaires 1 week before and 6 weeks and 6, 12, 18, and 24 months after CRT. Patients were compared to a reference group. A linear mixed-model analysis was used to assess changes in HRQOL over time, and whether this was associated with age, gender, comorbidity, and tumor sublocation. Results Significant differences for the majority of HRQOL scales were observed between patient and reference group at baseline, and follow-up. The course of HRQOL was different for survivors compared to non-survivors. In survivors, improvement over time was observed (in global quality of life, physical, role, and social function, fatigue, pain, swallowing, speech, social eating, and social contacts), while in non-survivors the pattern over time was either no changes in HRQOL or a deterioration (in physical function, social eating and contacts). In both survivors and non-survivors, emotional functioning improved after treatment, but deteriorated in the longer term. Patients with comorbidity reported worse physical function, and patients with oral/oropharyngeal cancer (compared to hypopharyngeal/laryngeal cancer) reported more oral pain and sexual problems, but fewer speech problems. Conclusions The course of HRQOL of HNSCC patients during the first 2 years after CRT is different for survivors compared to non-survivors and is associated with comorbidity and tumor subsite.
    Radiotherapy and Oncology 01/2014; · 4.52 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Selecting patients with head and neck cancer requiring a pre-treatment gastrostomy feeding tube is not straightforward. The nutritional status and functional deficits associated with the cancer, its treatment and long term side effects predicate the need for gastrostomy tube placement. However gastrostomy tubes are not without morbidity and are an added burden to the patient. Aim of this retrospective case series review was to evaluate the clinical characteristics of new H&N cancer patients treated with curative intent having gastrostomy placement with the intent of developing a protocol to help the timely selection of patients for pre-treatment gastrostomy insertion. A gastrostomy tube was placed in 32%. A regression model identified five independent predictors (p<0.001) to predict gastrostomy tube: overall clinical stage, tumour site, clinical T stage, patient age, and clinical N stage. A protocol to help the multi-disciplinary team (MDT) decision whether a pre-treatment gastrostomy tube should be placed is suggested.
    Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 01/2014; · 1.50 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The accurate definition of organs at risk (OARs) is required to fully exploit the benefits of intensity-modulated radiotherapy (IMRT) for head and neck cancer. However, manual delineation is time-consuming and there is considerable inter-observer variability. This is pertinent as function-sparing and adaptive IMRT have increased the number and frequency of delineation of OARs. We evaluated accuracy and potential time-saving of Smart Probabilistic Image Contouring Engine (SPICE) automatic segmentation to define OARs for salivary-, swallowing- and cochlea-sparing IMRT.
    Radiation oncology (London, England). 08/2014; 9(1):173.


Available from